Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1180)
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
5
Price
$779.69
Total Value
$3.90K
Shares Held After
17,789
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$778.30
Total Value
$1.56K
Shares Held After
17,794
% of Holdings
0.0%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Goff Brian — Director
Shares
3,870
Price
$28.96
Total Value
$112.08K
Shares Held After
147,733
% of Holdings
2.6%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
7
Price
$777.46
Total Value
$5.44K
Shares Held After
17,796
% of Holdings
0.0%
BioAge Labs, Inc. (BIOA)
RUBIN PAUL D — Chief Medical Officer
Shares
7,433
Price
$20.30
Total Value
$150.89K
Shares Held After
0
% of Holdings
100.0%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
1,165
Price
$30.58
Total Value
$35.63K
Shares Held After
411,855
% of Holdings
0.3%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
689
Price
$30.58
Total Value
$21.07K
Shares Held After
212,479
% of Holdings
0.3%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Washburn Theodore James Jr. — Principal Accounting Officer
Shares
798
Price
$28.96
Total Value
$23.11K
Shares Held After
6,140
% of Holdings
11.5%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Washburn Theodore James Jr. — Principal Accounting Officer
Shares
727
Price
$28.96
Total Value
$21.05K
Shares Held After
4,243
% of Holdings
14.6%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Washburn Theodore James Jr. — Principal Accounting Officer
Shares
698
Price
$28.96
Total Value
$20.21K
Shares Held After
2,595
% of Holdings
21.2%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
115,792
Price
$14.21
Total Value
$1.65M
Shares Held After
12,045,292
% of Holdings
1.0%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
83,561
Price
$14.33
Total Value
$1.20M
Shares Held After
11,929,500
% of Holdings
0.7%
Intellia Therapeutics, Inc. (NTLA)
BASTA JAMES — EVP, General Counsel
Shares
1,211
Price
$13.78
Total Value
$16.69K
Shares Held After
156,794
% of Holdings
0.8%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Milanova Tsveta — Chief Commercial Officer
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
41,591
% of Holdings
2.8%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Milanova Tsveta — Chief Commercial Officer
Shares
1,681
Price
$28.96
Total Value
$48.68K
Shares Held After
38,778
% of Holdings
4.2%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
8,071
Price
$2.12
Total Value
$17.14K
Shares Held After
110,832
% of Holdings
6.8%
Karyopharm Therapeutics Inc. (KPTI)
Cheng Sohanya Roshan — EVP & Chief Commercial Officer
Shares
4,604
Price
$9.41
Total Value
$43.32K
Shares Held After
107,317
% of Holdings
4.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
1,987
Price
$25.70
Total Value
$51.07K
Shares Held After
136,932
% of Holdings
1.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
193
Price
$25.91
Total Value
$5.00K
Shares Held After
136,932
% of Holdings
0.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
6,553
Price
$25.16
Total Value
$164.88K
Shares Held After
137,125
% of Holdings
4.6%
Intellia Therapeutics, Inc. (NTLA)
Clark Eliana — EVP, Chief Technical Officer
Shares
607
Price
$13.78
Total Value
$8.36K
Shares Held After
93,864
% of Holdings
0.6%
Arcutis Biotherapeutics, Inc. (ARQT)
Watanabe Todd — Director
Shares
1,068
Price
$25.91
Total Value
$27.68K
Shares Held After
785,957
% of Holdings
0.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Watanabe Todd — Director
Shares
36,281
Price
$25.16
Total Value
$912.85K
Shares Held After
787,025
% of Holdings
4.4%
Karyopharm Therapeutics Inc. (KPTI)
Mano Michael — EVP, CLO&Secretary
Shares
3,526
Price
$9.41
Total Value
$33.18K
Shares Held After
93,964
% of Holdings
3.6%
Karyopharm Therapeutics Inc. (KPTI)
Paulson Richard A. — Director
Shares
12,361
Price
$9.41
Total Value
$116.31K
Shares Held After
267,030
% of Holdings
4.4%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
276
Price
$30.58
Total Value
$8.44K
Shares Held After
164,658
% of Holdings
0.2%
Arcutis Biotherapeutics, Inc. (ARQT)
Edwards Larry Todd — Reporting Person's title: EVP, Chief Commercial Officer
Shares
103
Price
$25.91
Total Value
$2.67K
Shares Held After
175,178
% of Holdings
0.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Edwards Larry Todd — Reporting Person's title: EVP, Chief Commercial Officer
Shares
3,584
Price
$25.16
Total Value
$90.18K
Shares Held After
175,281
% of Holdings
2.0%
Karyopharm Therapeutics Inc. (KPTI)
Poulton Stuart — EVP, Chief Development Officer
Shares
5,101
Price
$9.41
Total Value
$48.00K
Shares Held After
94,328
% of Holdings
5.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
289,024
Price
$15.82
Total Value
$4.57M
Shares Held After
1,987,330
% of Holdings
12.7%
Ultragenyx Pharmaceutical Inc. (RARE)
Huizenga Theodore Alan — SVP, Chief Accounting Officer
Shares
1,632
Price
$22.80
Total Value
$37.21K
Shares Held After
48,670
% of Holdings
3.2%
Fennec Pharmaceuticals Inc. (FENC)
Raykov Rosty — Director
Shares
10,079
Price
$8.36
Total Value
$84.26K
Shares Held After
103,996
% of Holdings
8.8%
Arcutis Biotherapeutics, Inc. (ARQT)
Vairavan Latha — SVP Chief Financial Officer
Shares
81
Price
$25.91
Total Value
$2.10K
Shares Held After
87,754
% of Holdings
0.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Vairavan Latha — SVP Chief Financial Officer
Shares
2,772
Price
$25.16
Total Value
$69.74K
Shares Held After
87,835
% of Holdings
3.1%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
559
Price
$9.41
Total Value
$5.26K
Shares Held After
22,063
% of Holdings
2.5%
Liquidia Corp (LQDA)
Boyle Dana — Chief Accounting Officer
Shares
445
Price
$30.58
Total Value
$13.61K
Shares Held After
178,840
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
200
Price
$102.08
Total Value
$20.42K
Shares Held After
64,424
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
2,100
Price
$101.63
Total Value
$213.43K
Shares Held After
64,624
% of Holdings
3.1%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
600
Price
$100.19
Total Value
$60.12K
Shares Held After
66,724
% of Holdings
0.9%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
100
Price
$98.29
Total Value
$9.83K
Shares Held After
67,324
% of Holdings
0.1%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
800
Price
$102.00
Total Value
$81.60K
Shares Held After
64,424
% of Holdings
1.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
1,700
Price
$101.47
Total Value
$172.51K
Shares Held After
65,224
% of Holdings
2.5%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
400
Price
$100.12
Total Value
$40.05K
Shares Held After
66,924
% of Holdings
0.6%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
100
Price
$98.31
Total Value
$9.83K
Shares Held After
67,324
% of Holdings
0.1%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
851
Price
$102.20
Total Value
$86.97K
Shares Held After
289,569
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
21,329
Price
$101.60
Total Value
$2.17M
Shares Held After
290,420
% of Holdings
6.8%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
3,620
Price
$100.73
Total Value
$364.66K
Shares Held After
311,749
% of Holdings
1.1%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
3,500
Price
$99.76
Total Value
$349.15K
Shares Held After
315,369
% of Holdings
1.1%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
700
Price
$98.17
Total Value
$68.72K
Shares Held After
318,869
% of Holdings
0.2%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
1,187
Price
$28.96
Total Value
$34.38K
Shares Held After
74,406
% of Holdings
1.6%
Showing 851–900 of 1180 transactions (page 18 of 24)